top of page

MBT-2 Syngeneic Model

Rincon Bio offers efficacy studies using the MBT-2 Syngeneic Model at our U.S.-based facilities, with direct access to the scientists conducting your study.

Model Type:
Syngeneic
Organ:
Bladder
Derivation:
Metastatic lesion from mutagen induced bladder cancer in a C3H/He mouse
Mutations:
Unavailable
NCI60:
No
Weeks from stratification to termination (average):
5.5

MBT-2 Growth Curve

(Representative of studies performed at Rincon Bio)

Representative tumor growth curve for the MBT-2 syngeneic model from studies performed at Rincon Bio.

For more information on this model, including available control data, please Contact Us, or request a Quote below

All Xenograft Models

All Syngeneic Models

bottom of page